欧洲 API 中间体市场 - 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲 API 中间体市场 - 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Europe
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Europe Api Intermediates Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 49,400.00 Million
Diagram Market Size (Forecast Year)
USD 79,332.30 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>欧洲 API 中间体市场,按类型(兽药中间体、制药 / 大宗药物中间体)、产品(溴化合物、O-苄基沙丁胺醇、半硫酸盐、环氧乙烷、比索洛尔碱、手性 PCBHP、非那敏碱、氯苯那敏碱、溴苯那敏碱、美吡拉敏 / 吡拉明碱、6-氨基-1,3-二甲基尿嘧啶、茶碱、乙酰茶碱、黄嘌呤、腈类、其他)、治疗类型(自身免疫性疾病、肿瘤学、代谢性疾病、眼科、心血管疾病、传染病、神经病学、呼吸系统疾病、皮肤病学、泌尿科、其他)、客户(直接用户 / 制药公司、贸易商 / 批发商 / 分销商、协会 / 政府机构 / 私人机构)、最终用户(API 制造商、成品制造商)、分销渠道(直接招标、零售销售、其他)——行业趋势和 2030 年预测。

欧洲 API 中间体市场

欧洲 API 中间体市场分析和规模

制药公司积极参与研发 (R&D),以创造新药并改进现有配方。这项研发工作需要稳定供应高质量的 API 中间体。欧洲许多制药公司将 API 中间体的生产外包给第三方制造商,包括亚洲等其他地区的制造商。这种外包使欧洲公司能够降低生产成本并专注于药物开发和营销。生物仿制药(一种与现有生物制品高度相似的生物药物)的开发在欧洲呈上升趋势。生产生物仿制药需要可靠的 API 中间体供应,从而促进市场增长。

Data Bridge Market Research 分析,欧洲 API 中间体市场在 2022 年为 494 亿美元,预计到 2030 年将达到 793.323 亿美元,预计在 2023-2030 年预测期内的复合年增长率为 6.1%。这表明了市场价值。由于医疗保健领域的投资不断增加,“兽药中间体制药”在欧洲 API 中间体市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

欧洲 API 中间体市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

类型(兽药中间体、制药/大宗药物中间体)、产品(溴化合物、邻苄基沙丁胺醇、半硫酸盐、环氧乙烷、比索洛尔碱、手性 PCBHP、非那敏碱、氯苯那敏碱、溴苯那敏碱、美吡拉敏/吡拉明碱、6-氨基-1,3-二甲基尿嘧啶、茶碱、乙酰茶碱、黄嘌呤、腈类、其他)、治疗类型(自身免疫性疾病、肿瘤学、代谢性疾病、眼科、心血管疾病、传染病、神经病学、呼吸系统疾病、皮肤病学、泌尿科、其他)、客户(直接用户/制药公司、贸易商/批发商/分销商、协会/政府机构/私人机构)、最终用户(API 制造商、成品制造商)、分销渠道(直接投标、零售、其他)

覆盖国家

德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰、欧洲其他地区

涵盖的市场参与者

HIKAL Ltd.(印度)、Cambrex Corporation(美国)、Ganesh-Group(印度)、AlzChem Group AG(德国)、Vasudha Pharma(印度)、安养综合化工有限公司(韩国)、Sarex(印度)、Sandoo Pharmaceuticals and Chemicals Co., Ltd.(中国)、Atul Ltd(印度)、Sandoz International GmbH(诺华公司子公司)(德国)、Aceto(美国)、Supriya Lifescience Ltd.(印度)、Vertellus(美国)、Dishman Carbogen Amcis Ltd(印度)、Sanofi(法国)、Divi's Laboratories Limited(印度)、AARTI INDUSTRIES LIMITED(印度)、Aurobindo Pharma(印度)、BASF SE(德国)

市场机会

  • 慢性病发病率上升
  • 科技进步日新月异
  • 研发活动不断增加
  • 仿制药需求不断增长

市场定义

活性药物成分 (API) 中间体是用作合成或制造活性药物成分 (API) 的中间产品的化合物。API 中间体是制药制造过程中必不可少的组成部分,因为它们是创建最终 API 的基础。API 中间体是在生产活性药物成分 (API) 过程中合成的化合物。它们是化学合成途径中的中间阶段,它们经过进一步加工和修改,最终成为药品的 API。API 中间体在制药行业中至关重要,因为它们在确定最终药品的质量、纯度和功效方面发挥着至关重要的作用。

欧洲 API 中间体市场动态

驱动程序

  • 制药行业增长

欧洲制药业的特点是拥有大量新药候选药物和疗法。随着制药公司投资研发 (R&D) 将创新药物推向市场,它们需要稳定供应高质量的 API 中间体。每个新药开发项目都需要根据药物的分子结构量身定制的特定中间体。欧洲的制药公司从事广泛治疗领域的药物开发,包括肿瘤学、心血管疾病、神经病学、传染病和罕见疾病。治疗领域的多样性导致对 API 中间体的需求多种多样,从而刺激了市场需求。

  • 研发崛起

制药行业持续的研发工作催生了新药和新疗法,这需要特定的 API 中间体。欧洲的制药公司不断投资研发,以发现和开发新药和新疗法。药物发现和开发的早期阶段通常涉及合成和测试多种化合物,包括 API 中间体。随着越来越多的候选药物进入开发流程,对专用中间体的需求也在增加。研发工作通常侧重于开发针对特定患者群体或治疗需求的定制药物配方。这种定制需要合成与所需 API 分子结构和特性相匹配的独特 API 中间体。

机会

  • 不断增长的研究合作

欧洲制药公司与研究机构之间的合作通常会促成新型药物和疗法的开发。这些研究工作可能需要合成特定的 API 中间体。欧洲制药业的增长与对 API 中间体的需求密切相关。新药的开发、遵守监管标准、定制需求、外包实践以及向新兴市场的扩张都促使欧洲对高质量和可靠的 API 中间体的需求不断增加。

克制/挑战

  • 监管障碍

在欧洲,制药行业(包括 API 中间体行业)受到严格的监管。必须遵守良好生产规范 (GMP)、良好实验室规范 (GLP) 以及其他质量和安全标准。满足这些严格的要求可能成本高昂且耗时。欧洲非常重视环境保护。API 中间体制造工艺通常涉及使用化学品和溶剂。遵守环境法规、废物管理和可持续实践可能具有挑战性且成本高昂。

最新动态

  • 2021 年 1 月,Vertellus 被 Pritzker Private Capital 公司收购,该公司与北美的中型市场公司合作,并与该公司建立了长期合作关系。由于 Vertellus 被视为医疗保健、食品和农业、个人护理、运输和涂料等不同领域的领先公司或特种化学品提供商,因此 PPC 与该公司建立了合作伙伴关系。这帮助 Vertellus 公司提高了市场增长,从而推动了公司的收入
  • 2020 年 11 月,Cambrex Corporation 宣布公司将扩大 API 制造能力,以满足消费者日益增长的需求。该公司已投资 5000 万美元来提高其制造能力。API 制造的增加将直接增加中间体的产量和需求,这意味着公司必须增加 API 及其中间体的制造。此次扩张帮助公司提高了 API 及其中间体领域的产量,这将促进 API 中间体市场的增长

欧洲 API 中间体市场范围

欧洲 API 中间体市场根据类型、产品、治疗类型、客户、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

类型

  • 兽药中间体 医药
  • 原料药中间体

产品

  • 溴化合物
  • 邻苄基沙丁胺醇
  • 半硫酸盐、环氧乙烷
  • 比索洛尔碱
  • 手性 PCBHP
  • 苯海拉明碱
  • 氯苯那敏碱
  • 溴苯那敏碱
  • 美吡拉敏/吡拉明碱
  • 6-氨基-1,3-二甲基尿嘧啶
  • 茶碱
  • 乙酰茶碱
  • 黄嘌呤
  • 腈类
  • 其他的

治疗类型

  • 自身免疫性疾病
  • 肿瘤学
  • 代谢疾病
  • 眼科
  • 心血管疾病
  • 传染病
  • 神经病学
  • 呼吸系统疾病
  • 皮肤科
  • 泌尿科
  • 其他的

顾客

  • 直接用户/制药公司
  • 贸易商/批发商/分销商
  • 协会/政府机构/私营机构

最终用户

  • API 制造商
  • 成品制造商)

分销渠道

  • 直接招标
  • 零售销售
  • 其他的

欧洲 API 中间体市场分析/见解

对欧洲 API 中间体市场进行了分析,并按类型、产品、治疗类型、客户、最终用户和分销渠道提供了市场规模洞察和趋势。

欧洲 API 中间体市场报告涵盖的国家包括德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰和欧洲其他地区。

德国在市场份额和市场收入方面占据欧洲 API 中间体市场的主导地位,并将在 2023-2030 年的预测期内继续保持主导地位。这是因为医疗保健支出的增加将进一步推动该地区市场的增长率。此外,有利的健康补偿政策、慢性伤口的增加以及老龄人口的增长将进一步推动该地区市场的增长率。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

欧洲 API 中间体市场还为您提供每个国家/地区资本设备医疗保健支出增长、欧洲 API 中间体市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对欧洲 API 中间体市场的影响的详细市场分析。数据涵盖 2015-2020 年历史时期

竞争格局和欧洲 API 中间体市场份额分析

欧洲 API 中间体市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、区域业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对欧洲 API 中间体市场的关注有关。

欧洲 API 中间体市场的一些主要参与者包括:

  • HIKAL有限公司(印度)
  • Cambrex 公司 (美国)
  • Ganesh 集团 (印度)
  • AlzChem Group AG(德国)
  • Vasudha Pharma(印度)
  • 安阳综合化学有限公司(韩国)
  • Sarex(印度)
  • 三都医药化工有限公司(中国)
  • Atul 有限公司 (印度)
  • Sandoz International GmbH(德国)
  • Aceto(美国)
  • Supriya Lifescience Ltd.(印度)
  • Vertellus(美国)
  • Dishman Carbogen Amcis Ltd(印度)
  • 赛诺菲(法国)
  • Divi's Laboratories Limited(印度)
  • AARTI INDUSTRIES LIMITED(印度)
  • Aurobindo Pharma(印度)
  • 巴斯夫公司(德国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE API intermediates MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
    1. CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
    2. Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
      1. Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
    3. EUROPE API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
      1. THE U.S.-CHINA TRADE WAR
      2. INDO-CHINA GEOPOLITICAL ISSUES
      3. CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
      4. CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
    4. Cost Analysis
    5. Analysis on China API intermediates:
      1. Conclusion:
    6. porters five forces model
    7. Pestel analysis
    8. Europe API INTERMEDIATES market: regulatORY
      1. THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
      2. CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
      3. EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
      4. JAPAN REGULATORY FOR API INTERMEDIATES
      5. MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
  5. EUROPE API INTERMEDIATES MARKET: CONCLUSION
    1. TOP PRODUCTS AND THERAPEUTIC AREAS
    2. ADDITIONAL
  6. CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
  7. LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
  8. Market Overview
    1. Drivers
      1. HIGH BURDEN OF CHRONIC DISEASES
      2. increase in aging population
      3. utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
      4. increasing disease awareness and education
      5. research and development regarding pharmaceutical API and their intermediates
    2. restrainTs
      1. availability of sub-standard and counterfeit drugs
      2. product recalls
      3. high manufacturing cost
      4. stringent government regulations for api intermediates
    3. opportunities
      1. strategic initiatives by the market players
      2. increasing healthcare expenditure
      3. SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
      4. RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
    4. challenges
      1. disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
      2. lack of workforce in pharma industries
  9. Impact of COVID 19 on Europe API Intermediates market
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
    5. CONCLUSION
  10. Europe API intermediates MARKET, BY type
    1. overview
    2. pharmaceutical intermediates/ bulk drug intermediates
    3. Veterinary Drug Intermediates
  11. Europe API intermediates MARKET, BY product
    1. overview
    2. Nitriles
    3. bromo compound
    4. Chiral PCBHP
    5. Chlorpheniramine Base
    6. Brompheniramine Base
    7. Pheniramine Base
    8. O-Benzyl Salbutamol
    9. Bisoprolol Base
    10. Hemisulfate
    11. Oxirane
    12. Mepyramine/Pyrilamine Base
    13. Theofylline
    14. Acefylline
    15. Xanthine
    16. 6-Amino-1,3-Dimethyl Uracil
    17. others
  12. Europe API intermediates MARKET, BY therapeutic type
    1. overview
    2. Cardiovascular Diseases
    3. Metabolic Diseases
    4. infectious Diseases
    5. respiratory Diseases
    6. neurology
    7. oncology
    8. Autoimmune Disease
    9. Dermatology
    10. ophthalmology
    11. urology
    12. others
  13. Europe API intermediates MARKET, BY customers
    1. overview
    2. Direct Users/Pharma Companies
    3. Traders/Wholesalers/Distributors
    4. Associations/Govt. Institutions/Pvt Institutions
  14. Europe API intermediates MARKET, BY End User
    1. overview
    2. API manufacturer
    3. finished product manufacturer
  15. Europe API intermediates MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. Retail Sale
    4. others
  16. Europe API Intermediates Market by geography
    1. EUROPE
      1. GERMANY
      2. U.K
      3. ITALY
      4. SPAIN
      5. FRANCE
      6. NETHERLANDS
      7. RUSSIA
      8. SWITZERLAND
      9. TURKEY
      10. AUSTRIA
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF ASIA PACIFIC
  17. Europe API Intermediates Market: COMPANY landscape
    1. company share analysis: Europe
  18. swot analysis
  19. company profile
    1. aurobindo pharma
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORFOLIO
      5. RECENT DEVELOPMENTS
    2. Divi’s laboratories limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. basf se
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. CAMBRIX CORPORATION
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Sandoz International GmbH (a subsidiary of Novartis AG)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. aceto
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. hikal ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. alzchem group ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. vertellus
      1. COMPANY SNAPSHOT
      2. PRODUCT CATEGORIES
      3. RECENT DEVELOPMENTS
    10. sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    11. atul ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. aarti industries limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. vasudha pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. anyang general chemical co., Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    15. dishman carbogen amics ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    16. ganesh-group
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. levachem company limited
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    18. sandoo pharmaceuticals and chemicals co., ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. sarex
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. SUPRIYA LIFESCIENCE LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  20. questionnaire
  21. related reports

表格列表

TABLE 1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)

TABLE 2 Percentage Break up of Cost

TABLE 3 Tentative Land Requirement

TABLE 4 Percentage Break up of Plant Area

TABLE 5 Table: 1 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 7 MARKET PLAYERS OF API INTERMEDIATES

TABLE 8 Sales Data of API intermediates for 2019/2020

TABLE 9 Europe API intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 10 Europe pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 11 Europe Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 12 Europe API intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 13 Europe nitriles in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 14 Europe bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 15 Europe chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 16 Europe chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 17 Europe brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 18 Europe pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 19 Europe O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 20 Europe bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 21 Europe hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 22 Europe oxirane in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 23 Europe mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 24 Europe theofylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 25 Europe acefylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 26 Europe Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 27 Europe 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 28 Europe others in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 29 Europe API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)

TABLE 30 Europe cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)

TABLE 31 Europe metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 32 Europeinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 33 Europe respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 34 Europe neurology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 35 Europe oncology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 36 Europe autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 37 Europe dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 38 Europe ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 39 Europe urology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 40 Europe others in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 41 Europe API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)

TABLE 42 Europe Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 43 Europe Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 44 Europe Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 45 Europe API intermediates Market, By END USER, 2019-2028 (USD Million)

TABLE 46 Europe API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 47 Europe finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 48 Europe API intermediates Market, By distribution channel, 2019-2028 (USD Million)

TABLE 49 Europe direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 50 Europe retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 51 Europe Othersin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 52 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 53 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 54 Europe API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 55 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 56 Europe API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 57 Europe API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 58 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 59 Germany API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 60 Germany API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 61 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 62 Germany API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 63 Germany API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 64 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 66 U.K API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 67 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 68 U.K API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 69 U.K API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 70 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 71 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 72 Italy API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 73 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 74 Italy API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 75 Italy API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 76 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 77 Spain API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 78 Spain API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 79 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 80 Spain API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 81 Spain API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 82 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 83 France API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 84 France API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 85 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 86 France API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 87 France API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 88 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 89 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 90 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 91 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 92 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 93 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 94 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 95 Russia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 96 Russia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 97 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 98 Russia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 99 Russia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 100 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 101 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 102 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 103 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 104 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 105 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 106 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 107 Turkey API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 108 Turkey API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 109 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 110 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 111 Turkey API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 112 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 113 Austria API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 114 Austria API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 115 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 116 Austria API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 117 Austria API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 118 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 119 Norway API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 120 Norway API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 121 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 122 Norway API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 123 Norway API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 124 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 125 Hungary API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 126 Hungary API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 127 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 128 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 129 Hungary API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 130 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 131 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 132 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 133 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 134 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 135 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 136 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 137 Ireland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 138 Ireland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 139 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 140 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 141 Ireland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 142 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 143 Poland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 144 Poland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 145 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 146 Poland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 147 Poland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 148 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 149 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

图片列表

FIGURE 1 Europe API INTERMEDIATES MARKET: SEGMENTATION

FIGURE 2 EUROPE API INTERMEDIATES MARKET: DATA TRIANGULATION

FIGURE 3 Europe API intermediates Market: DROC ANALYSIS

FIGURE 4 Europe API intermediates market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe API intermediates Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE API intermediates MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE API intermediates MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE API intermediates MARKET: MARKET type COVERAGE GRID

FIGURE 11 Europe API intermediates market: SEGMENTATION

FIGURE 12 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE Europe API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the Europe API INTERMEDIATES MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Europe API Intermediates market

FIGURE 15 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019

FIGURE 16 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020

FIGURE 17 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020

FIGURE 18 EUROPE CAUSES OF DEATHs WITH THE CHRONIC DISEASES

FIGURE 19 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)

FIGURE 20 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)

FIGURE 21 Europe API intermediates market: BY type, 2021

FIGURE 22 Europe API intermediates market: BY type, 2019-2028 (USD Million)

FIGURE 23 Europe API intermediates market: BY type, CAGR (2021-2028)

FIGURE 24 Europe API intermediates market: BY type, LIFELINE CURVE

FIGURE 25 Europe API intermediates market: BY product, 2021

FIGURE 26 Europe API intermediates market: BY product, 2019-2028 (USD Million)

FIGURE 27 Europe API intermediates market: BY product, CAGR(2021-2028)

FIGURE 28 Europe API intermediates market: BY product, LIFELINE CURVE

FIGURE 29 Europe API intermediates market: BY therapeutic type, 2021

FIGURE 30 Europe API intermediates market: BY therapeutic type, 2019-2028 (USD Million)

FIGURE 31 Europe API intermediates market: BY therapeutic type, CAGR (2021-2028)

FIGURE 32 Europe API intermediates market: BY therapeutic type, LIFELINE CURVE

FIGURE 33 Europe API intermediates market: BY customers, 2021

FIGURE 34 Europe API intermediates market: BY customers, 2019-2028 (USD Million)

FIGURE 35 Europe API intermediates market: BY customers, CAGR (2021-2028)

FIGURE 36 Europe API intermediates market: BY customers, LIFELINE CURVE

FIGURE 37 Europe API intermediates market: BY end user, 2021

FIGURE 38 Europe API intermediates market: BY end user, 2019-2028 (USD Million)

FIGURE 39 Europe API intermediates market: BY end user, CAGR (2021-2028)

FIGURE 40 Europe API intermediates market: BY end user, LIFELINE CURVE

FIGURE 41 Europe API intermediates market: BY distribution channel, 2021

FIGURE 42 Europe API intermediates market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 43 Europe API intermediates market: BY distribution channel, CAGR (2021-2028)

FIGURE 44 Europe API intermediates market: BY distribution channel, LIFELINE CURVE

FIGURE 45 Europe API Intermediates market: SNAPSHOT (2020)

FIGURE 46 Europe API INTERMEDIATEs market: BY COUNTRY (2020)

FIGURE 47 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)

FIGURE 48 Europe API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 49 Europe API Intermediates market: BY type (2021-2028)

FIGURE 50 Europe API Intermediates market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe API intermediates market size will be worth USD 79,332.30 million by 2030.
The growth rate of the Europe API intermediates market is 6.1% in the forecast by 2030.
Pharmaceutical industry growth & rising research and development are the growth drivers of the Europe API intermediates market.
Type, product, therapeutic type, customers, end user, and distribution channel are the factors on which the Europe API intermediates market research is based.
Major companies in the Europe API intermediates market are HIKAL Ltd.(India), Cambrex Corporation (U.S.), Ganesh-Group (India), AlzChem Group AG (Germany), Vasudha Pharma (India), Anyang General Chemical Co.,Ltd.(South Korea), Sarex (India), Sandoo Pharmaceuticals and Chemicals Co., Ltd.(China), Atul Ltd (India), Sandoz International GmbH (a subsidiary of Novartis AG) (Germany), Aceto (U.S.), Supriya Lifescience Ltd. (India), Vertellus (U.S.), Dishman Carbogen Amcis Ltd (India), Sanofi (France), Divi's Laboratories Limited (India), AARTI INDUSTRIES LIMITED (India), Aurobindo Pharma (India), BASF SE (Germany)